Buthionine sulfoximine (BSO) induces decreased glutathione (GSH) and trypanothione [T(SH) 2 ] pools in trypanosomatids, presumably because only gamma-glutamylcysteine synthetase (cECS) is blocked. However, some BSO effects cannot be explained by exclusive cECS inhibition; therefore, its effect on the T(SH) 2 metabolism pathway in Trypanosoma cruzi was re-examined. Parasites exposed to BSO did not synthesize T(SH) 2 even when supplemented with cysteine or GSH, suggesting trypanothione synthetase (TryS) inhibition by BSO. Indeed, recombinant cECS and TryS, but not GSH synthetase, were inhibited by BSO and kinetics and docking analyses on a TcTryS 3D model suggested BSO binding at the GSH site. Furthermore, parasites overexpressing cECS and TryS showed~50% decreased activities after BSO treatment. These results indicated that BSO is also an inhibitor of TryS.
American trypanosomiasis or Chagas disease is a systemic and chronic parasitic illness caused by the human parasite Trypanosoma cruzi. The estimated infected persons in American countries are 5.7 million, whereas the estimated population being at risk of infection is 70 million [1] . Although the disease is mainly endemic of Latin American countries, infected people are now distributed worldwide because of human emigration and nonvectorial transmission.
During human infection, the parasite is exposed to reactive oxygen species produced by the host immune response, or as a consequence of pharmacologic intervention with benznidazole or nifurtimox, the current drugs used for its treatment [2, 3] . To contend with oxidative stress, T. cruzi has an antioxidant system based on trypanothione [T(SH) 2 ] instead of glutathione (GSH) like in human cells (Scheme 1) reviewed in [4, 5] . Trypanothione is a conjugate of two GSH molecules covalently bound by a spermidine (Spd) molecule which is synthesized in an ATP-consuming reaction catalyzed by trypanothione synthetase (TryS). The de novo GSH synthesis starts with cysteine (Cys) and glutamate which are bound in an ATP-consuming reaction by gamma-glutamylcysteine synthetase (cECS) to form gamma-glutamylcysteine (cEC). The latter is further linked to glycine in another ATP-consuming reaction catalyzed by glutathione synthetase (GS) to produce GSH. On the other hand, Spd can be de novo synthesized from putrescine (Put) and decarboxylated S-adenosylmethionine by Spd synthase, or it can be imported from the extracellular milieu by highaffinity plasma membrane polyamine transporters.
The enzymes of this particular T(SH) 2 metabolism have been regarded as attractive therapeutic sites [3] [4] [5] [6] , Abbreviations BSO, buthionine sulfoximine; Cys, cysteine; GS, glutathione synthetase; GSH, glutathione; Put, putrescine; Spd, spermidine; T(SH) 2 , reduced trypanothione; TryS, trypanothione synthetase; cEC, gamma-glutamylcysteine; cECS, gamma-glutamylcysteine synthetase.
and it has been proposed that inhibition of GSH synthesis should affect T(SH) 2 synthesis and the antioxidant defense of the parasite [7] . It is well established that buthionine sulfoximine (BSO) is a potent inhibitor of cECS. The BSO isomers inhibit by acting as structural analogs of glutamate [8, 9] . The L-(S)-BSO isomer is phosphorylated by cECS resulting in a compound that simulates a chemical transition state previous to the formation of cEC, and tightly binds to the catalytic site blocking catalytic [8, 10] . The L-(R)-BSO isomer is not phosphorylated but competitively (vs. glutamate) inhibits the enzyme with a Ki = 0.15 mM for the human enzyme [10] . The D-(S,R)-isomers do not inhibit the cECS activity [10] .
Buthionine sulfoximine decreases the thiol pools in T. cruzi epimastigotes. Parasites exposed to 0.5 mM BSO for 1-8 days show 20-80% less total thiols [11] [12] [13] , and BSO lowers (30-40%) the IC 50 values for benznidazole and nifurtimox on parasite growth [13] . Indeed, BSO treatment of different T. cruzi strains revealed that inhibition of the thiol metabolites synthesis increases the susceptibility to trypanocidal drugs [11, 13, 14] .
Most of the described BSO effects on thiol metabolites have been explained by assuming exclusive cECS inhibition. However, decreased GSH and T(SH) 2 levels in BSO-treated, (60 and 120 lM) wild-type Trypanosoma brucei cells are not restored by supplementing with 80 lM GSH, which contrasts with the recovered thiol levels in T. brucei cECS knockdown cells supplemented with GSH [15] . These authors explained this result by proposing that external GSH transport is also inhibited by BSO; hence other pathway sites may very likely be also BSO targets. However, BSO inhibition specificity on trypanothione metabolism of trypanosomatid parasites has not been systematically examined. Therefore, in the present study, a thorough analysis of metabolite pools and enzyme activities of the T(SH) 2 metabolism in T. cruzi treated with this inhibitor was performed which led to identifying TryS as an additional BSO target.
Experimental strategy

Cell culture
Trypanosoma cruzi epimastigotes Quere´taro strain, DTU I [16] were grown at 28°C in liver infusion tryptose (LIT) medium (0.5% triptose, 0.5% liver infusion, 0.4% NaCl, 0.04% KCl, 0.42% Na 2 HPO 4 , 0.2% glucose) supplemented with 10% FBS (ByProductos, Guadalajara, Jalisco, Mexico), 25 lgÁmL À1 hemin, 100 lg streptomycinÁmL À1 , and 100 U penicillinÁmL À1 (Sigma-Aldrich, St, Louis MO, USA) reaching a final pH = 7. In this medium the basal Cys concentration was 62 lM (n = 2), whereas GSH was below the limit of detection of the assay (< 25 nM).
BSO exposure
Cultures of 50 mL were initiated at a cell density of 0.7 9 10 6 parasitesÁmL À1 and were grown for 48 h to reach the exponential growth phase (2.8 À 3.2 9 10 6 parasitesÁmL À1 ). The cell culture was split in aliquots of 5 mL and poured into 15-mL tubes, with one of them serving as control, whereas the others received different concentrations (0.25-20 mM) of freshly prepared DL-buthionine-(S,R)-sulfoximine (B2640; Sigma) dissolved in Milli-Q water and then the cells were further incubated for 24 h. Thereafter, the cell density (number of parasitesÁmL À1 ) of each culture was determined by direct cell counting with a Neubauer chamber. The relative cell growth was the difference between the cell density attained after 24 h of incubation with the inhibitor minus the initial cell density before adding the inhibitor. A second protocol was performed in which the inhibitor was added at the beginning of the cell culture and the cell density was daily monitored for 9 days. To determine the DL-(S,R)-BSO concentration required to attain 50% growth decrease (EC 50 ), the relative cell growth in the presence of the inhibitor was normalized to the relative growth in its absence. The growth rate (l) corresponds to the slope given by a semilog plot of log cell density vs. time at the different inhibitor concentrations; these values were further normalized to the l value obtained in the absence of the inhibitor. The BSO stability in the parasite culture medium is unknown, but if it is unstable, then its effects on the parasite physiology would originate from acting in a bolus fashion. Similar experiments were performed in 25-mL parasite cultures with 0-3 mM DL-(S,R)-BSO and supplemented with 0-0.1 mM of either Cys or N-acetyl-L-Cys (NAC) and 0-1 mM of either GSH or GSH-monoethyl ester (GMEE; Sigma), all dissolved in Milli-Q water. The cells were incubated for 24 h at 28°C; then 1-mL aliquots were separated for protein determination by the Lowry method [17] in PBS-washed cell pellets and the rest was used for metabolite determination as follows. The cells were collected by centrifugation at 4500 g for 10 min at 4°C and the cell pellet (~100 lL) was washed once with 10 mL PBS buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , pH 7.4) and later with 1 mL PBS. The cellular pellet for metabolite determination was stored at À70°C until use (within the next 7 days). All the samples of each individual titration experiments (control and experimental curves) were analyzed the same day.
Metabolite determination
Thiol metabolites were determined as described before, but with some modifications [18] . Briefly, the cellular pellets were resuspended in 90 lL of cold lysis buffer (20 mM HEPES pH 7.4, 0.15 mM KCl, 1 mM EDTA, 20 mM dithiothreitol) and the cell soluble fraction was obtained by three quick cycles of freezing in liquid nitrogen/thawing at 37°C (~4 min in total), followed by centrifugation at 20 817 g for 10 min at 4°C. The soluble fractions were reduced with an excess of sodium borohydride for 10 min on ice; then the protein and excess borohydride and its salts were discarded by adding perchloric acid (3% v/v), mixing and centrifuging at 4500 g for 2 min at 4°C (protocol 1). Twenty microliters of the acidic sample was used for thiol metabolite separation carried out by high-performance liquid chromatography in a Waters apparatus (Milford, MA, USA) using a reverse-phase C-18 column of 3-lm particle size (Altima, Columbia, MD, USA) previously equilibrated with 99% trifluoroacetic acid (0.1% v/v in water) and 1% acetonitrile, which also served as separating phase. Separated thiols were postcolumn derivatized with dithionitrobenzoic acid (Sigma) in 100 mM Na 2 HPO 4 at pH 8.0 and detected by UV-VIS spectrophotometry at 412 nm with the HPLCcoupled detector.
To test the thiol stabilities during sample processing, two other protocols of thiol extraction were assessed. The pellets of freshly harvested cells were resuspended in lysis buffer and immediately treated with perchloric (3% v/v; protocol 2) or sulfosalycilic (5% v/v; protocol 3) acids, vortexed, incubated for 20 min on ice, and centrifuged. Similar T(SH) 2 levels were obtained in the three protocols in nonsupplemented and thiol-supplemented parasites; however, Cys and GSH were three to five times lower in the PCA and SSA extraction protocols (Fig. S1A) . Thus, protocol 1 yielded significantly higher total thiol levels because it allows recovery of dithiol molecules such as oxidized glutathione. Hence, the protocol of cell lysis/thiol reduction/ acid precipitation used in this work seems to be reliable for simultaneously determining the changes in the intracellular Cys, GSH, and T(SH) 2 contents. Therefore, with the extraction protocol 1, the total amount of reduced thiol equivalents (thiol groups derived from the reduced forms, and from the oxidized and mixed disulfides reduced by NaBH 4 ) was determined throughout the present study. Furthermore, thiol stabilities through time in cells stored at À70°C vs. fresh cells were monitored (Fig. S1B) . The average thiol contents were similar in both cell samples, although the storage increased the standard deviation.
The polyamines Put and Spd were determined as described before [18] .
cECS and TryS overexpression in epimastigotes
The genes of interest were amplified by PCR. For cECS gene amplification, genomic DNA from the T. cruzi Quer etaro strain was used as template. The primers used were: cECS sense 5 0 -GCACGATATCATGGGTCT CTTGA-3 0 and cECS antisense 5 0 -CGATGCGGCCGCT-TACTC ACGGG-3 0 . These primers were designed using the sequence previously published for the cECS from T. cruzi CL Brener strain (XM_808833.1) and contained EcoRV and NotI restriction sites, respectively. The PCR amplification protocol was 10 min of denaturation at 95°C, followed by 40 cycles of 3-min denaturation at 95°C, 15-s annealing at 60°C, and 3-min elongation at 72°C; and a final step of 5 min at 72°C. The PCR product was cloned in the pJET 2.1 vector (Thermo Fisher Scientific, Waltham, MA, USA) and further subcloned in the EcoRV and NotI restriction sites of the pTREXn T. cruzi transfection vector [19] and sequenced. No difference with the cECS amino acid sequence from T. cruzi CL Brener strain was observed. The TryS gene was amplified from a previous expression vector containing the TryS gene of the T. cruzi Ninoa strain [18] . The amplification primers were based on the TryS sequence of the Silvio strain (AF311782.1): sense 5 0 -GGCAAGCTTATGACGACTCTAAAGTCTTTGGCGG-3 0 and antisense 5 0 -GGCGGCCGCTCACGTTTTCAA GCCACCACCG-3 0 ; these primers contained restriction sites for HindIII and NotI, respectively. The PCR protocol was similar as above except for using an annealing temperature of 60°C. The PCR product was directly ligated into the pTREXn vector using the restriction sites and verified by sequencing. Trypanosoma cruzi epimastigotes were transfected by electroporation as described before [20] . Briefly, 3 9 10 8 epimastigotes harvested at the exponential growth phase were resuspended in cold 1-mL incomplete LIT medium (with neither serum nor hemin) and were transferred to a 2-mm electroporation cell. Then, 100 lg of plasmidic pTREXn DNA constructs (previously purified by cesium chloride gradient) were added and the sample subjected to a pulse of 300 V for 70 ms using a BTX electroporator (Harvard Apparatus, Holliston, MA, USA). After electroporation, the transfected parasites were poured into 15-mL sterile conical tubes with 5 mL of complete LIT medium and incubated at 28°C for 48 h. Afterwards, the parasites were cultured in LIT medium in the presence of 500 lg geneticinÁmL À1 (Gibco, NY, Grand Island, USA) for 15 days with two subsequent selection procedures of 15 days in the presence of the antibiotic. As a control to assess efficiency in the transfection and selection procedures, epimastigotes were transfected with the pTREXn vector containing the GFP. Expression of the GFP protein was indeed displayed by 100% parasites. For further experiments, pTREXn without GFP was used to transfect cells (mock cells). Transfected parasites were exposed to DL-(S, R)-BSO as described in section BSO exposure.
Recombinant cECS, GS and TryS
The recombinant proteins were purified from previously obtained Escherichia coli BL21(DE3) cells containing plasmids that allow overexpression of the enzymes [18] . The overexpression protocol was modified to that of autoinduction [21] . Briefly, a preinoculum of bacteria grown in LB medium for 18 h at 37°C with orbital agitation at 200 r.p.m. was generated. Then, 2.5-mL preinoculum aliquots were diluted in 250 mL of ZYM autoinduction medium (1% tryptone, 0.5% yeast extract, 25 mM Na 2 HPO 4 , 25 mM KH 2 PO 4 , 50 mM NH 4 Cl, 5 mM Na 2 SO 4 , 2 mM MgSO 4 , 0.5% glycerol, 0.05% glucose, 0.2% a-lactose) and incubated for 4 h at 37°C under agitation and further for 16 h at 25°C. The proteins were purified by metal-affinity chromatography as described before [18] .
Enzyme activity determination and BSO inhibition
Recombinant cECS, GS, and TryS activities were determined under initial rate conditions as described before [18] . Briefly, the ADP produced by their reactions was determined at 37°C by coupling with excess pyruvate kinase and lactate dehydrogenase (at least 0.6 U PYK/0.9 U LDH; Sigma) and following the NADH oxidation at 340 nm in a diode-array Agilent spectrophotometer. The reaction mixture (0.5 mL) contained assay buffer (100 mM HEPES pH 7.4, 100 mM KCl, 5 mM MgSO 4 , 1 mM EDTA), 2 mM PEP, 0.2 mM NADH, 2 mM ATP plus specific substrates: 1.3 mM glutamate and 2.1 mM Cys to start the cECS reaction; 8 mM Gly and 0.4 mM cEC to start the GS reaction; 11 mM Spd and 1 mM GSH to start the TryS reaction. The amount of protein used was 2-7.5 lg which was within the linearity of the assay. Saturation curves for
TryS were performed at variable GSH with saturating cosubstrate concentrations.
To determine the effect of BSO on recombinant T. cruzi cECS, GS, and TryS enzymes, individual aliquots of 2-7.5 lg of recombinant protein were preincubated at 4°C with different concentrations (0-2 mM) of water-dissolved DL-(S,R)-BSO in 100 lL of enzymatic assay buffer (100 mM HEPES pH 7.4, 100 mM KCl, 5 mM MgSO 4, 1 mM EDTA) for 1-6 h. Afterward, the whole mix was used to determine the remaining activity using the standard enzymatic assay; in this, the maximal DL(S,R)-BSO final concentration was 0.4 mM.
Furthermore, the kinetics of the effect of the two diastereomers L-(S,R)-BSO (B2515; Sigma) on the enzymes was determined without preincubation, by directly adding the inhibitor to the enzymatic assay with saturating cosubstrates; in this case, the reactions were started by adding variable concentrations of the specific thiol substrates. In addition, the enzymes were preincubated for 1 h with L-(S, R)-BSO as described above and the remaining activity was determined under initial rate conditions (whose duration was up to 10 min). Double reciprocal and Dixon plots were used to determine the type of inhibition and inhibition constant (Ki app ) values [22] . The activity of the coupling enzymes PYK and LDH was not affected by 3 mM of DL-(S,R)-BSO or 1 mM L-(S,R)-BSO after 1 h incubation.
To determine the effect of BSO in the enzymes within the parasites, wild-type epimastigotes (Quer etaro strain), parasites transformed with empty vector (mock), and parasites overexpressing cECS or TryS were cultured in 50 mL of LIT medium to the exponential phase of growth and exposed to 0-3 mM DL-(S,R)-BSO as described in BSO exposure. The cells were harvested, washed with PBS, and the cell-soluble fractions were obtained as described in Metabolite determination except that the cell lysis buffer also contained 1 mM phenylmethanesulfonyl fluoride. Enzyme activities were determined in the enzymatic assay protocol described above for recombinant enzymes but following the next procedures. Mixtures for two reactions were prepared containing 0.2-0.5 mg of cell-soluble protein and all the enzymatic assay components except the specific thiol substrate. The mix was divided into two fractions but only one was supplemented with the required thiol. The sample lacking the thiol substrate accounted for the contaminating ATPase activity present in the soluble cell fractions, which was subtracted from the activity in the complete reaction.
Modeling of T. cruzi TryS and molecular docking analysis
A three-dimensional model of T. cruzi TryS was obtained by homology modeling using the SWISSMODEL software (available at http://swissmodel.expasy.org/) [23] . The template used for modeling was the structure of Leishmania major TryS (PDB: 2VOB) [24] . The structures of GSH and L-BSO were downloaded from PubChem (https:// pubchem.ncbi.nlm.nih.gov/). The protein structure model and ligands were prepared for docking using the software ADT 1.5.2 [25] . Docking analysis was carried out using the software Autodock 4.2.5.1 (available at http://autodock.sc ripps.edu/) [26] . After docking, the 100 best conformations for each ligand were selected and then clustered for analysis using the software ADT 
Results
DL-(S,R)-BSO effect on cell growth
Trypanosoma cruzi epimastigotes grown for 48 h (exponential growth phase) and then treated with DL-(S, R)-BSO for further 24 h (Fig. 1A) yielded an EC 50 value of 3.3 AE 1.4 mM (n = 6), which was lower to that previously reported of 13.6 AE 0.52 mM in a 10 days exposure to L-(S,R)-BSO [13] . Therefore, a similar experiment to the reported one was performed adding the inhibitor at the beginning of the culture and monitoring parasite growth for 9 days (Fig. 1B ). An EC 50 value of 6.3 AE 2.4 mM (n = 3) on the growth rate (l) was now obtained (Fig. 1C) , which was still lower to the reported one [13] .
DL-(S,R)-BSO effect on parasite thiol metabolite content DL-(S,R)-BSO effect on nonthiol-supplied cells
The steady-state intermediate metabolite levels of a particular pathway depend on the rates of the enzymes that produce a given metabolite and those that consume it; if a pathway enzyme is inhibited (rate-limited), then its substrates should accumulate, whereas its products should decrease (crossover theorem) [27, 28] . Hence, the changes in the T(SH) 2 synthesis pathway intermediates (Scheme 1) and T(SH) 2 seen as the pathway 0 s end product, can provide clues about how BSO affects the T(SH) 2 pathway enzymes.
At 3 mM DL-(S,R)-BSO, parasite viability was not significantly affected (90% mobile parasites; data not shown) but the relative cell growth decreased by 60% (Fig. 1) . In agreement with previous reports [13, 15] , DL-(S,R)-BSO administration promoted (a) significant decrease in the T(SH) 2 content starting at the lowest inhibitor concentrations of 0.1 mM; (b)~50% decrease in the GSH pool; and (c) a marked decrease in the Cys level only at 0.1 mM (probably due to competitive inhibition of BSO on Cys synthesis), but which was increased at higher inhibitor concentrations (Fig. 2, left panel) most probably due to cECS inhibition.
DL-(S,R)-BSO effect on Cys-supplied cells
To circumvent the limiting effect of the parasites' Cys pool on the cECS rate (Scheme 1), the cells were supplemented with increasing Cys (or Cys analogs) concentrations. Thus, the inhibitory effect of BSO on cECS and pathway thiol metabolites can be directly analyzed. Up to 0.1 mM Cys was supplied to the parasites, which is close to the physiological concentrations present in human plasma (0.212 mM) [29] and Cys + cystine in serum (0.096 mM) [30] . There were concentration-dependent increases in the T(SH) 2 contents reaching up to 4.5-fold at 0.1 mM Cys (Figs 3A and 2 middle panel). Supplementation with higher Cys concentrations up to 1 mM yielded a similar pattern in thiol pools to that observed with 0.1 mM Cys (data not shown). In contrast, lower increases in T(SH) 2 levels (2.5-fold) were attained when parasites were supplemented with permeable NAC (Fig. 3A) . These observations indicated that T. cruzi epimastigotes can readily take up Cys for T(SH) 2 synthesis. Afterward, in the presence of DL-(S,R)-BSO and 0.1 mM external Cys, (a) internal Cys built up as a consequence of Cys uptake and cECS inhibition; (b) GSH level gradually decreased, stabilizing at 50% of the control cells value; and (c) T(SH) 2 was severely depleted at inhibitor concentration ≥ 0.25 mM despite the presence of GSH in the cell (Fig. 2 middle panel) . The T(SH) 2 depletion suggested either GSH limitation for TryS reaction or an inhibitory effect of DL-(S,R)-BSO on TryS (Scheme 1).
DL-(S,R)-BSO effect on GSH-supplied cells
To further test the latter hypotheses, the controlling effect of cECS on the GSH pool and the putative GSH limitation of TryS (Scheme 1) were circumvented by directly supplementing the parasites with 0.3-5 mM free GSH or 0.3-1 mM of the permeable GSH analog GMEE. These GSH concentrations are within the physiological intracellular concentrations found in animal cells (0.5-13.7 mM) and liver (5-10 mM) [31] [32] [33] . Addition of external GSH (0.3-1 mM) gradually increased T(SH) 2 2 pool by only 75% (Fig. 3B) . Perhaps the ethyl group of GMEE was not efficiently removed by the parasite esterases, preventing its covalent binding to Spd by TryS. A concentration of 1 mM GSH was chosen for supplementing the parasites in the presence of increasing concentrations of DL-(S,R)-BSO. At inhibitor concentrations lower than 0.5 mM, the GSH content was up to 80% higher than in control and Cys-supplemented cells; however, this did not prevent the gradual decrease in the T(SH) 2 levels ( Fig. 2 right panel) . It has been reported that TryS from several trypanosomatids are potently inhibited by GSH (reviewed in [4] ). However, as shown in Fig. S2 and previously reported [18] , TryS from T. cruzi is inhibited by GSH at very high, nonphysiological concentrations (Ki GSH : 7.5-11.2 mM) which are not reached under any of the conditions tested in Fig. 2 (at most 1.8 mM in the GSH-supplemented parasites in the absence of inhibitor). Hence, the decreased T(SH) 2 level in the DL-(S, R)-BSO-treated parasites originated from the BSO inhibitory effect on TryS rather than from metabolic inhibition of TryS by GSH.
T(SH) 2 level was not further increased by 5 mM external GSH (data not shown). In contrast, GMEE increased the T(SH)
On the other hand, the levels of Put and Spd did not significantly change in the parasites supplemented with Cys and GSH in the absence or presence of the inhibitor (Fig. S3 ), ruling out a BSO effect on the polyamine supply required for T(SH) 2 synthesis. However, in nonthiol-supplied cells in the presence of the inhibitor, the polyamine contents showed a tendency to accumulate, as expected from an inhibited T(SH) 2 synthesis.
Effect of DL-(S,R)-BSO on the enzymes present within the parasites
It was next determined whether DL-(S,R)-BSO actually inhibited the GSH and T(SH) 2 syntheses enzymes within the parasites. Since no reliable determinations of cECS and TryS activities in wild-type cells can be attained due to their low activities and high levels of an interfering ATPase activity, T. cruzi epimastigotes were transfected with plasmids allowing the overexpression of these enzymes. The enzyme activities were determined in the parasites exposed for 24 h to 3 mM DL-(S, R)-BSO. The cECS and TryS activities were reliably determined in the overexpressing parasites, whereas GS could be determined in both wild-type and overexpressing cells. DL-(S,R)-BSO treatment brought about inhibition of cECS (63%) and TryS (55%) activities, whereas GS activity was not affected (Table 1) .
On the other hand, the growth of wild-type cells showed higher susceptibility to DL-(S,R)-BSO in comparison to the three transfected parasites (Fig. 4) . The EC 50 value for BSO was 3.9-fold higher in the cells overexpressing cECS, which correlated with their higher T(SH) 2 content (Table 2 ). In contrast, Fig. 3 . Effect of different thiol suppliers on the thiol intracellular contents in Trypanosoma cruzi epimastigotes. Parasites were supplemented with the indicated concentrations of (A) Cys or the permeable NAC; and (B) GSH or GMEE. After 24 h, the parasites were harvested and the intracellular thiol contents were determined by HPLC. One hundred percent thiol was equivalent to Cys, 4.2 AE 1.8; GSH, 6.9 AE 1; T(SH) 2 , 4.3 AE 1.6 nmolÁ(mg protein) À1 (n = 5).
+ GSH or GMEE (mM) + Cys or NAC (mM)
overexpressing TryS cells showed nonsignificant higher resistance than wild-type and mock cells (Table 2) . A puzzling observation was that the latter cells showed higher Cys, GSH, and T(SH) 2 levels than wild-type and overexpressing (oe)-TryS cells, probably due to off-side effects. Nevertheless, after 3 mM DL-(S,R)-BSO treatment, undetectable levels of T(SH) 2 were found in all cell types despite the presence of high GSH levels ( Table 2) .
Effect of different BSO isomers on recombinant enzymes of T(SH) 2 synthesis
The type of inhibition mechanism of different BSO isomers was further analyzed. The mixture of the four isomers DL-(S,R)-BSO directly added to the enzyme assays did not inhibit recombinant T. cruzi TryS activity; hence, the enzyme was preincubated with the inhibitor. It was first determined that TryS preincubation at 37°C for 30 min or at 28°C for 1.5 h in the absence of inhibitor induced significant loss of its activity; however, incubation at 4°C for up to 6 h was not detrimental, although at longer times, activity was lost (Fig. S4A) . Hence, a protocol of 6-h incubation at 4°C was selected for testing the DL-(S,R)-BSO effect on the three recombinant enzymes. The DL-(S, R)-BSO mixture did not inhibit GS, whereas a pattern of partial inhibition on cECS and TryS was observed (Fig. 5A) . Subsequently, the effect of only two of the BSO stereoisomers, the L-(S,R)-BSO mixture, was determined on the recombinant enzymes (Fig. 5B-F) . These . < 2 means below the limit of detection of activity after subtracting the ATPase activity present in the cell preparation. n = 2-4 soluble fractions from independent cell cultures. (Table 2) was determined as described in the material and methods section. For clarity, only one side of the SD value is shown. The experimental data were fitted to an exponential decay equation, but no mechanistic implications were meant. For EC 50 values n = 3-5 independent cell cultures. The statistical analysis used for EC 50 was two-tailed Student 0 s t-test: *P < 0.05, **P < 0.001 vs. wild-type. For thiol contents n = 2 independent cell cultures, ND means below the limit of detection of 0.6 nmol thiolÁ(mg cell protein) À1 . ) at 37°C were 0.5 AE 0.16 (n = 3) for cECS, 4.1 AE 2.3 (n = 3) for GS, and 1.5 AE 0.7 (n = 5) for TryS. For clarity, the experimental data were fitted to an exponential decay equation, but no mechanistic implications were meant and only one side of the SD is shown. (B, C, and D) Inhibition of L-(S,R)-BSO on cECS, TryS, and GS, respectively. The inhibitor was directly added to the standard enzymatic assay (immediate inhibition) or the enzyme was preincubated with the inhibitor for 1 h at 4°C and later the remaining activity was assayed in the standard enzymatic assay at 37°C (preincubated). One hundred percent activities (lmolesÁ(min 9 mg protein)
À1
) at 37°C were 0.7 AE 0.3 (n = 6) for cECS, 1.6 AE 0.3 (n = 6) for GS, and 2 AE 0.8 (n = 6) for TryS. (E) Representative plot of the effect of L-(S,R)-BSO on TryS at variable GSH concentrations. Inset. Dixon plot showing that the inhibitor is a partial inhibitor against GSH (the curves fit to a hyperbola) [22] . (F) Double reciprocal plot of the experiment in E showing that BSO is competitive against GSH. Inset. the intersect on the X axis of the plot of the double reciprocal slopes against inhibitor is equivalent to À1/Ki app [22] .
forms of the inhibitor were more potent and allowed to determine their effect in the enzymatic assay without enzyme preincubation. As a control, it was determined that the enzyme activities were not significantly altered (Fig. S4B ) during the duration of the reaction assay (up to 15 min) in the absence of BSO.
Gamma-glutamylcysteine synthetase was~40% partially inhibited when L-(S,R)-BSO was directly added to the enzymatic assay; this inhibition was increased to 60% when the enzyme was preincubated with the inhibitor for 1 h (Fig. 5B) . For TryS, L-(S,R)-BSO proved to be a weaker partial inhibitor, attaining only 10% inhibition in the immediate reaction but reaching 30% inhibition when the enzyme was preincubated for 1 h (Fig. 5C ). At the lowest remaining inhibitor concentration of 2 lM, the enzyme was more inhibited than in the immediate reaction, which suggested a low-affinity constant value for the inhibitor or an irreversible inhibition. In contrast, GS inhibition by L(S,R)-BSO was observed at concentrations higher than 1 mM of the inhibitor in both the immediate or preincubated protocols (Fig. 5D) .
The L-(S,R)-BSO inhibition on TryS assayed without preincubation and at variable GSH concentrations (Fig. 5E ) showed higher inhibitory effect at low GSH concentration. Double reciprocal (Fig. 5F ) and Dixon plots (insets in Fig. 5E ,F) data analyses [22] indicated that L-(S,R)-BSO is a partial competitive inhibitor against GSH, with a Ki app value of 171 AE 65 lM (n = 3).
Modeling BSO binding to TcTryS
A three-dimensional model of TryS from T. cruzi (TcTryS) was obtained with validation parameters described in Fig. S5 . The highest identity of the enzyme was obtained with the crystal structure of L. major TryS (LmTryS; PDB: 2VOB) [24] with an amino acid sequence identity of 57.8% and a protein sequence coverage of 99%. Structural alignment of the TcTryS model and LmTryS crystal structure overlapped almost perfectly (Fig. 6A) . A previous structure superposition analysis of LmTryS and glutathionylspermidine synthetase amidase from E. coli [24] indicated that the GSH-binding site in the synthetase domain of LmTryS was a groove formed by residues R328, S349, S351, D403, E407, E408, M459, and S462. In the TcTryS model, the groove was formed by residues R316, S337, S339, D391, D395, E396, M447, and T450 (Fig. 6B) .
Docking analysis indicated that GSH may indeed bind to this groove in the TcTryS (theoretical K d = 1.52 mM; Fig. 6C ). The majority of these residues were conserved with respect to LmTryS, except for D395 and T450 which were Glu and Ser, respectively, in the L. major enzyme. Furthermore, docking analysis with L-BSO indicated that it may bind to the groove proposed for GSH binding (Fig. 6C) . In the TcTryS model, the sulfoximine moiety is stabilized by residues D391, E396, M447, and T450 which also stabilize the gamma-glutamyl moiety of GSH (Fig. 6C) , while the butyl group of BSO is stabilized in a hydrophobic patch formed by the carbon backbones of A338, S339, D395, E396, T399, and T445. These model predictions suggested that BSO binds to the GSH-binding site and were in agreement with the kinetic analysis.
Discussion cECS and TryS activity inhibition by BSO
The T(SH) 2 depletion induced by BSO and inability of external GSH supply to fully restore its level cannot be explained by exclusive BSO inhibition on cECS. The supplementation experiments with Cys and GSH (to circumvent the controlling role of cECS on the GSH pool) and enzyme activity determinations within the parasites treated with BSO allowed to elucidate that the changes in the T(SH) 2 contents induced by BSO were mediated by inhibition of cECS as well as TryS. Furthermore, the results of the kinetic analysis on the recombinant enzyme and docking analysis in a 3D model suggested that BSO competes with GSH for the GSH-binding site in TryS. To our knowledge this is the first report showing that TryS can be inhibited in vitro and in vivo by BSO; hence, a consequence of the unspecific action of BSO is that it targets the two main controlling enzymes of T(SH) 2 synthesis in the parasite [18] .
Thiol metabolite supply and BSO multitarget inhibition in T. cruzi Due to limitations in obtaining high amounts of the trypomastigote and amastigote forms for metabolic analyses, the present work was carried out with the epimastigote stage of the parasite. However, a higher susceptibility to BSO can be predicted in the human infective forms since they have approximately half the thiol contents than the epimastigote form [13, 34] . On the other hand, Cys and GSH external supply may have physiological meaning, besides being used as a methodological strategy. When T. cruzi trypomastigotes and amastigotes infect host cells they get access to higher Cys and GSH concentrations, for example, in cells (1-8 mM GSH), rat liver mitochondria (5-10 mM), kidney (4.2 lmolÁg Cysteine was readily taken up by the parasites and used for T(SH) 2 synthesis; in consequence, Cys significantly accumulated when added and cECS was inhibited by BSO (Fig. 2) . A high affinity Cys transporter (Km Cys of 49.5 lM, V max of 13 pmolÁmin À1 Á10 À7 cells) has been reported for T. cruzi which seems to be inducible under Cys depletion and low pH [37] . Our results indirectly demonstrated that Cys transport was active in the parasites, but it was unknown whether it was induced or already expressed under the culture conditions without Cys supplementation. Glutathione also entered the parasites promoting T(SH) 2 synthesis; however, the latter was inhibited by BSO with a different response pattern to that attained in Cys supplemented cells in the presence of the inhibitor (Fig. 2) . At BSO concentrations lower than 0.5 mM, the higher levels of T(SH) 2 in the GSH-supplemented parasites in comparison to the Cys-supplemented parasites might be the consequence of (a) high GSH availability for synthesis and (b) GSH competition with BSO for binding to TryS. In contrast, when the parasites were supplemented with Cys, this amino acid is not a substrate of TryS and therefore does not compete with BSO for binding to the TryS GSH site, with the consequent drastic depletion of T(SH) 2 with 0.25 mM BSO (Fig. 2) . These results supported that TryS was in vivo effectively inhibited by BSO, which was further demonstrated in the TryS-overexpressing parasites exposed to the inhibitor.
On the other hand, it has been proposed that GSH transport may also be inhibited by BSO [15] which cannot be ruled out in the GSH supplementation experiments. Nevertheless, at least a fraction of external GSH appeared to enter into the cells and accumulate at BSO concentrations < 0.5 mM (Fig. 2 right panel) . The possibility that extracellular GSH hydrolysis functions as an external Cys supply for cECS cannot be ruled out either; however, since BSO also inhibits cECS, then the most probable source of the accounted increased intracellular GSH in the parasites was the external GSH through plasma membrane transport. Furthermore, in GSHsupplied cells, extracellular GSH degradation alone would be unable to rescue T(SH) 2 synthesis in cECS and growth in GS T. brucei down-regulated cells [15, 38] , indicating that GSH transport is feasible in trypanosomatids.
The GSH plasma membrane transport has not been studied in trypanosomatids; however, GSH internalization through plasma membranes can be carried out by specific GSH transporters (reviewed in [39] ). GSH transporters have been biochemically detected or their presence has been indirectly shown in different cell models, like in this paper. So far, the molecular identity of only one GSH transporter (the Hgt1p GSH transporter in the yeast Saccharomyces cerevisiae) has been reported [40] and a GSH transporter gene has been identified only in the parasite Plasmodium falciparum [41] . Hence, GSH transport is an issue deserving further study in T. cruzi.
Effect of BSO on parasite growth
The EC 50 value (6.3 mM) for BSO on growth of the Mexican T. cruzi Quer etaro strain used here was within the same order of magnitude to that previously reported (13.6 AE 0.52 mM) for the MF strain [13] .
Parasites overexpressing cECS were 3.9-fold more resistant to BSO because they contained 10-fold higher cECS activity and displayed approximately twofold higher Cys, GSH, and T(SH) 2 contents than wild-type cells. In marked contrast, parasites overexpressing TryS exhibited a marginal increased resistance to BSO in comparison to WT cells and no significant increased T(SH) 2 content despite showing 25-fold increased TryS activity. A likely explanation is that, in cells with greater TryS expression and in the absence of external Cys and GSH sources, cECS increases its degree of control on T(SH) 2 synthesis [18] (i.e., becomes more flux-limiting due to its low basal levels of activity). Then, the similar sensitivity of the TryS transfectants to BSO in comparison to the WT cells probably derived from the deleterious effect on the pathway flux induced by the BSO inhibition on the wild-type level of cECS activity and the ensuing GSH limitation for TryS activity. Further analyses on a possible metabolic regulation in TryS transfectants remain to be analyzed.
Conclusion
Buthionine sulfoximine is a multitarget inhibitor of T(SH) 2 synthesis in T. cruzi by blocking cECS and TryS. Although BSO is highly toxic [9] , it may serve as a lead compound for drug design studies against TryS. Since the compound induced only a partial inhibition on cECS and TryS and showed mainly a cytostatic effect on the parasites, BSO analogs with improved inhibitory effects could be generated. Hence, studies on therapeutic synergism of antichagasic canonical drugs such as benznidazol with BSO analogs to decrease parasite infection with less toxic effects, may be worth not to be abandoned. 
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